Biden administration discussing whether it must scale back ambitious Covid-19 vaccine booster plan

Sep 03, 2021 0 Replies

That's because the booster regimen must be approved by the FDA and they are just now analyzing reams and reams of data from Pfizer only, with the other manufacturers late in completing their data packages, or even starting in the case of J&J. It sounds like they don't want to do a piecemeal booster program limited to a specific vaccine or vaccines.



formatting link


Join the Discussion

Have something to add? Share your thoughts — no account required.

Didn't find your answer?

Ask the community — no account required